Stock Market News

Lilly’s weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea

2024.12.20 17:27

By Bhanvi Satija

(Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly (NYSE:)’s weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug greenlighted to directly treat patients with the common sleeping disorder.

The regulator approved the drug for moderate to severe obstructive sleep apnea in adults with obesity, the company said.

The approval opens up a wide market of patients for Lilly at a time when demand for Zepbound is already surging.

It could also strengthen Lilly’s case with commercial insurers and employers, who have previously hesitated to cover the drug due to its high cost.

Shares of the Indianapolis-based drugmaker were up 1.14% in after-market trading following the announcement.

Sleep apnea patients stop breathing briefly while sleeping, disturbing the sleep cycle and causing long-term complications such as heart conditions. The condition affects roughly one billion people globally.

“Too often, obstructive sleep apnea is brushed off as ‘just snoring’ – but it’s far more than that,” said Julie Flygare, CEO of non-profit organization Project Sleep.

Common treatments for the condition include CPAP machines, which involve wearing a mask over the face while sleeping, surgery, as well as losing weight.

Zepbound and Lilly’s widely used diabetes drug, Mounjaro, both chemically called tirzepatide, belong to a class of drugs called GLP-1 agonists.

Originally developed for type 2 diabetes, they also reduce food cravings and cause the stomach to empty more slowly.

U.S.-based Lilly and Danish rival Novo Nordisk (NYSE:) are testing their blockbuster obesity drugs for a range of conditions as they race to show that they have other health benefits.

Regulators can expand approval for medicines if new data shows them to be effective in other therapeutic areas.

The FDA’s approval is based on data from two trials involving 469 participants, in which Zepbound helped ease breathing difficulties in patients with moderate to severe obstructive sleep apnea.

The drugmaker published the full data in June, showing the drug helped resolve the disorder in up to 52% of patients in these trials.

Trial data also showed that Zepbound lowered the so-called biomarkers of sleep apnea, including low blood oxygen and blood pressure, which can indicate heart disease.

Government-backed Medicare plans for adults aged 65 and older and those with disabilities are barred from covering weight-loss treatments, though the Biden administration has proposed to expand the coverage of anti-obesity drugs.

© Reuters. FILE PHOTO: An injection pen of Eli Lilly’s Zepbound is displayed in New York City, U.S., December 11, 2023.  REUTERS/Brendan McDermid/File Photo

If President-elect Donald Trump’s incoming administration backs the move, the program would be effective from 2026.

Medicare only began covering Novo Nordisk’s Wegovy after it gained approval for reducing the risk of heart attacks and strokes in March.



Source link

Related Articles

Back to top button
bitcoin
Bitcoin (BTC) $ 101,370.16 1.64%
ethereum
Ethereum (ETH) $ 3,228.29 1.66%
xrp
XRP (XRP) $ 3.14 6.73%
tether
Tether (USDT) $ 0.999041 0.03%
solana
Solana (SOL) $ 236.95 0.72%
bnb
BNB (BNB) $ 675.30 0.07%
dogecoin
Dogecoin (DOGE) $ 0.346277 1.07%
usd-coin
USDC (USDC) $ 1.00 0.01%
cardano
Cardano (ADA) $ 0.997411 2.70%
staked-ether
Lido Staked Ether (STETH) $ 3,222.55 1.77%
tron
TRON (TRX) $ 0.235754 5.03%
chainlink
Chainlink (LINK) $ 24.37 3.12%
avalanche-2
Avalanche (AVAX) $ 35.39 1.79%
stellar
Stellar (XLM) $ 0.444819 4.34%
wrapped-steth
Wrapped stETH (WSTETH) $ 3,860.48 1.71%
wrapped-bitcoin
Wrapped Bitcoin (WBTC) $ 101,051.07 1.75%
sui
Sui (SUI) $ 4.33 1.45%
hedera-hashgraph
Hedera (HBAR) $ 0.340255 5.53%
the-open-network
Toncoin (TON) $ 5.04 5.53%
shiba-inu
Shiba Inu (SHIB) $ 0.00002 0.83%
weth
WETH (WETH) $ 3,221.58 2.18%
polkadot
Polkadot (DOT) $ 6.30 3.15%
leo-token
LEO Token (LEO) $ 9.68 0.13%
parkcoin
Parkcoin (KPK) $ 1.11 2.23%
litecoin
Litecoin (LTC) $ 116.90 2.69%
bitget-token
Bitget Token (BGB) $ 7.04 6.60%
bitcoin-cash
Bitcoin Cash (BCH) $ 425.33 1.47%
uniswap
Uniswap (UNI) $ 13.25 1.80%
hyperliquid
Hyperliquid (HYPE) $ 20.11 2.74%
official-trump
Official Trump (TRUMP) $ 32.48 31.53%
wrapped-eeth
Wrapped eETH (WEETH) $ 3,413.80 2.75%
pepe
Pepe (PEPE) $ 0.000015 0.39%
usds
USDS (USDS) $ 1.00 1.40%
near
NEAR Protocol (NEAR) $ 5.02 4.44%
ethena-usde
Ethena USDe (USDE) $ 0.997533 0.16%
aave
Aave (AAVE) $ 330.44 9.86%
aptos
Aptos (APT) $ 8.44 2.00%
internet-computer
Internet Computer (ICP) $ 9.64 0.56%
ondo-finance
Ondo (ONDO) $ 1.26 4.23%
ethereum-classic
Ethereum Classic (ETC) $ 25.46 2.11%
monero
Monero (XMR) $ 205.65 3.58%
vechain
VeChain (VET) $ 0.045441 2.73%
polygon-ecosystem-token
POL (ex-MATIC) (POL) $ 0.43597 0.17%
algorand
Algorand (ALGO) $ 0.425271 9.83%
crypto-com-chain
Cronos (CRO) $ 0.130514 2.70%
dai
Dai (DAI) $ 1.00 0.02%
okb
OKB (OKB) $ 58.10 3.08%
mantle
Mantle (MNT) $ 1.03 9.99%
mantra-dao
MANTRA (OM) $ 3.57 0.36%
render-token
Render (RENDER) $ 6.61 1.58%